GLP- 2 Tirzepatide is a synthetic peptide with dual activity as a GLP-1 and GIP receptor agonist, researched for its broad benefits in metabolic health. Studies suggest it may lower blood glucose, improve insulin sensitivity, promote satiety, and support significant weight loss. Additional research indicates it can enhance glucose tolerance, reduce adipose tissue, and improve cardiovascular risk factors, making it a promising agent for comprehensive metabolic support.